The Court has left in place a ruling that revives the Plaintiff’s pay-for-delay dispute against drug makers GlaxoSmithKline and Teva. Read more
While the negotiated deal benefited Teva and GSK, the deal was not structured with any concern or interest for purchasers or consumers who need treatment for epilepsy, bipolar disorder, and... Read more
Some antiseizure drugs used to treat epilepsy as well as depression, chronic pain, migraine, bipolar disorder, and other conditions are said to be associated with a higher risk of suicide an... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.